Biblio
Export 1129 results:
Author [ Title
Filters: First Letter Of Last Name is T [Clear All Filters]
“Cognitive, Functional, and Emotional Changes During the COVID-19 Pandemic in Greek Patients with Neurocognitive Disorders.”, J Alzheimers Dis, vol. 88, no. 2, pp. 537-547, 2022.
, “Cognitive Outcomes in Autosomal-Dominant Alzheimer's Disease: A Comprehensive Review from a Colombian Kindred with the Presenilin-1 E280A Mutation.”, J Alzheimers Dis, vol. 101, no. 2, pp. 397-415, 2024.
, “Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit.”, J Alzheimers Dis, vol. 52, no. 1, pp. 171-8, 2016.
, “Cognitive Rehabilitation in Alzheimer's Disease: A Controlled Intervention Trial.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1315-1324, 2017.
, “Cognitive Reserve in Alzheimer's Dementia: Diagnostic Accuracy of a Testing-the-Limits Paradigm.”, J Alzheimers Dis, vol. 52, no. 2, pp. 519-28, 2016.
, “Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 1, pp. 115-135, 2017.
, “Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1143-1160, 2017.
, “Combustion-Derived Nanoparticles in Key Brain Target Cells and Organelles in Young Urbanites: Culprit Hidden in Plain Sight in Alzheimer's Disease Development.”, J Alzheimers Dis, vol. 59, no. 1, pp. 189-208, 2017.
, “Common Variant in PLD3 Influencing Cerebrospinal Fluid Total Tau Levels and Hippocampal Volumes in Mild Cognitive Impairment Patients from the ADNI Cohort.”, J Alzheimers Dis, vol. 65, no. 3, pp. 871-876, 2018.
, “Common Variant in PLD3 Influencing Cerebrospinal Fluid Total Tau Levels and Hippocampal Volumes in Mild Cognitive Impairment Patients from the ADNI Cohort.”, J Alzheimers Dis, vol. 65, no. 3, pp. 871-876, 2018.
, “Common Variant in PLD3 Influencing Cerebrospinal Fluid Total Tau Levels and Hippocampal Volumes in Mild Cognitive Impairment Patients from the ADNI Cohort.”, J Alzheimers Dis, vol. 65, no. 3, pp. 871-876, 2018.
, “A Common Variant in the MC1R Gene (p.V92M) is associated with Alzheimer's Disease Risk.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1065-1074, 2017.
, “Community-Dwelling People Screened Positive for Dementia in Primary Care: A Comprehensive, Multivariate Descriptive Analysis Using Data from the DelpHi-Study.”, J Alzheimers Dis, vol. 52, no. 2, pp. 609-17, 2016.
, “Comorbid Depression and Diabetes as a Risk for Mild Cognitive Impairment and Alzheimer's Disease in Elderly Mexican Americans.”, J Alzheimers Dis, vol. 47, no. 1, pp. 129-36, 2015.
, “Comorbid Mild Cognitive Impairment and Depressive Symptoms Predict Future Dementia in Community Older Adults: A 24-Month Follow-Up Longitudinal Study.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1473-1482, 2016.
, “Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach.”, J Alzheimers Dis, vol. 89, no. 1, pp. 193-207, 2022.
, “Comparative Analysis of Cortical Microinfarcts and Microbleeds using 3.0-Tesla Postmortem Magnetic Resonance Images and Histopathology.”, J Alzheimers Dis, vol. 59, no. 3, pp. 951-959, 2017.
, “Comparative Analysis of Cortical Microinfarcts and Microbleeds using 3.0-Tesla Postmortem Magnetic Resonance Images and Histopathology.”, J Alzheimers Dis, vol. 59, no. 3, pp. 951-959, 2017.
, “Comparative Analysis of Cortical Microinfarcts and Microbleeds using 3.0-Tesla Postmortem Magnetic Resonance Images and Histopathology.”, J Alzheimers Dis, vol. 59, no. 3, pp. 951-959, 2017.
, “Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease”, J Alzheimers Dis, vol. 98, no. 3, pp. 825-835, 2024.
, “Comparison of Different Hypotheses Regarding the Spread of Alzheimer's Disease Using Markov Random Fields and Multimodal Imaging.”, J Alzheimers Dis, vol. 65, no. 3, pp. 731-746, 2018.
, “Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics.”, J Alzheimers Dis, vol. 52, no. 1, pp. 51-64, 2016.
, “Comparison of Model-Based Indices of Cerebral Autoregulation and Vasomotor Reactivity Using Transcranial Doppler versus Near-Infrared Spectroscopy in Patients with Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 56, no. 1, pp. 89-105, 2017.
, “Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil.”, J Alzheimers Dis, vol. 90, no. 1, pp. 161-172, 2022.
, “Comprehensive Characterization of the Pyroglutamate Amyloid-β Induced Motor Neurodegenerative Phenotype of TBA2.1 Mice.”, J Alzheimers Dis, vol. 63, no. 1, pp. 115-130, 2018.
,